LBTSF (Almirall) Other Operating Expense: $746 Mil (TTM As of Mar. 2026)


LBTSF Almirall SA LBTSF
84 GF Score
Price $15.35
GF Value $16.66
! 4 Warning Signs
View Full Analysis

What is Almirall Other Operating Expense?

Almirall LBTSF 84 Other Operating Expense is $746 Mil as of Mar. 2026. GuruFocus rates LBTSF with a GF Score™ of 84/100 and a GF Value™ of $16.66. The stock has 4 warning signs investors should review.

Almirall's Other Operating Expense for the three months ended in Mar. 2026 was $39 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $746 Mil.

Almirall's quarterly Other Operating Expense increased from Sep. 2025 ($-223 Mil) to Dec. 2025 ($639 Mil) but then declined from Dec. 2025 ($639 Mil) to Mar. 2026 ($39 Mil).

Almirall's annual Other Operating Expense increased from Dec. 2023 ($496 Mil) to Dec. 2024 ($534 Mil) and increased from Dec. 2024 ($534 Mil) to Dec. 2025 ($678 Mil).

Almirall Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Almirall's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Other Operating Expense Chart

Almirall Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 523.37 515.88 495.92 534.38 677.77

Almirall Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.41 291.26 -223.03 638.98 38.85
LBTSF
84GF Score
Almirall SA LBTSF
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almirall Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $746 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $746 Mil mean?
Almirall (LBTSF) has a Other Operating Expense of $746 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Almirall and its competitors.
Is Almirall's Other Operating Expense too high?
Almirall's current Other Operating Expense is $746 Mil. Overall, Almirall has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Other Operating Expense compare to ZTS and UTHR?
Almirall's Other Operating Expense of $746 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Almirall and its competitors. Almirall's current Other Operating Expense is $746 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Other Operating Expense of $746 Mil. The stock's GF Value™ is $16.66, compared to a current price of $15.35 — trading 7.9% below its estimated fair value. The current Other Operating Expense is $746 Mil. Almirall's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Almirall (LBTSF), the current Other Operating Expense is $746 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (LBTSF) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of $15.35 is trading 7.9% below its estimated GF Value™ of $16.66.

Key valuation signals for LBTSF:

  • Other Operating Expense: $746 Mil
  • GF Value™: $16.66 vs. price of $15.35 (7.9% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Other Exchanges 0O9B:UKALM:SpainE2Z:Germany
Address Ronda General Mitre 151, Barcelona, ESP, 08022
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
84GF Score

Get the complete analysis for LBTSF

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.35
Price
$16.66
GF Value